Viral Pneumonitis Is Increased in Obese Patients during the First Wave of Pandemic A(H1N1) 2009 Virus

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Kok, Jen ^a   Blyth, Christopher C ^b,c   Foo, Hong ^d   Bailey, Michael J ^e   Pilcher, David V ^e,f,g   Webb, Steven A ^h,i   Seppelt, Ian M ^j,k   Dwyer, Dominic E ^a   Iredell, Jonathan R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^d LIVERPOOL HOSPITAL   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f Australian and New Zealand Intensive Care Society   (Australia)

^g ALFRED HOSPITAL   (Australia)

^h ROYAL PERTH HOSPITAL   (Australia)

ⁱ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^j NEPEAN HOSPITAL   (Australia)

^k UNIVERSITY OF SYDNEY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; MORTALITY; OBESITY; PROTEIN BLOOD LEVEL; SURVIVOR; TREND STUDY; VIRUS PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; C-REACTIVE PROTEIN; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; OBESITY; PANDEMICS; PNEUMONIA, VIRAL; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84873920842     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055631     Document Type: Article

References (50)

1. ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, et al. (2009) Critical care services and 2009 H1N1 Influenza in Australia and New Zealand. N Engl J Med 361: 1925-1934.
2. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, et al. (2009) Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58(RR-8): 1-52.
3. Ho YC, Wang JL, Wang JT, Wu UI, Chang CW, et al. (2009) Prognostic factors for fatal adult influenza pneumonia. J Infect 58: 439-445.
4. Australian Government Australian Institute of Health and Welfare. Australian's health 2010. Available: http://www.aihw.gov.au/publication-detail/?id=6442468376&libID=6442468374&tab=2. Accessed 9 July 2012.
5. New Zealand Ministry of Health. A portrait of health: key results of the 2006/07 New Zealand health survey. Available: http://www.moh.govt.nz/moh.nsf/pagesmh/7601/File/body-size-ch2.pdf. Accessed 9 July 2012.
6. Louie JK, Acosta M, Samuel MC, Schechter R, Vugia DJ, et al. (2011) A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1) Clin Infect Dis. 52: 1-12.
7. Marti A, Marcos A, Martinez JA, (2001) Obesity and immune function relationships. Obes Rev 2: 131-140.
8. Smith AG, Sheridan PA, Harp JB, Beck MA, (2007) Diet-induced obese mice have increased morality and altered immune responses when infected with influenza virus. J Nutr 137: 1236-1243.
9. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB, (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282: 2131-2135.
10. Tsatsanis C, Margioris AN, Kontoyiannis DP, (2010) Association between H1N1 infection severity and obesity: adiponectin as a potential etiologic factor. J Infect Dis 202: 459-460.
11. Lam YY, Mitchell AJ, Holmes AJ, Denyer GS, Gummesson A, et al. (2011) Role of the gut in visceral fat inflammation and metabolic disorders. Obesity 19: 2113-2120.
12. Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, et al. (2004) Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 109: 3022-3028.
13. Memoli B, Procino A, Calabrò P, Esposito P, Grandaliano G, et al. (2007) Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor. Am J Physiol Endocrinol Metab 293: E1030-E1035. Available: http://ajpendo.physiology.org/content/293/4/E1030.long. Accessed 9 July 2012.
14. Osterholm MT, (2005) Preparing for the next pandemic. N Engl J Med 352: 1839-1842.
15. Rello J, Rodríguez A, Ibañex P, Socias L, Cebrian J, et al. (2009) Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care 13: R148. Available: http://ccforum.com/content/13/5/R148. Accessed 9 July 2012.
16. Falagas ME, Kompoti M, (2006) Obesity and infection. Lancet Infect Dis 6: 438-446.
17. Louie JK, Acosta M, Winter K, Jean C, Gavali S, et al. (2009) Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 302: 1896-1902.
18. Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, et al. (2010) Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS ONE 5: e9694. Available: http://www.plosone.org/article/info:doi/10/1371/journal.pone.0009694. Accessed 9 July 2012.
19. Myles PR, Semple MG, Lim WS, Openshaw PJ, Gadd EM, et al. (2012) Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax 67: 709-717.
20. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, et al. (2011) Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 8: e1001053. Available: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001053. Accessed 9 July 2012.
21. Kwong JC, Campitelli MA, Rosella LC, (2011) Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis 53: 413-421.
22. Díaz E, Rodríguez A, Martin-Loeches I, Lorente L, del Mar Martín M, et al. (2011) Impact of obesity in patients infected with 2009 influenza A(H1N1). Chest 139: 382-386.
23. Estenssoro E, Ríos FG, Apezteguía C, Reina R, Neira J, et al. (2010) Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med 182: 41-48.
24. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, et al. (2009) Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302: 1872-1879.
25. Rodríguez A, Martin-Loeches I, Bonastre J, Olaechea P, Álvarez-Lerma F, et al. (2011) First influenza season after the 2009 pandemic influenza: report of the first 300 ICU admissions in Spain. Med Intensiva 35: 208-216.
26. Hogue CW Jr, Stearns JD, Colantuoni E, Robinson KA, Stierer T, et al. (2009) The impact of obesity on outcomes after critical illness: a meta-analysis. Intensive Care Med 35: 1152-1170.
27. Martino JL, Stapleton RD, Wang M, Day AG, Cahill NE, et al. (2011) Extreme obesity and outcomes in critically ill patients. Chest 140: 1198-1206.
28. Riscili BP, Anderson TB, Prescott HC, Exline MC, Sopirala MM, et al. (2011) An assessment of H1N1 influenza-associated acute respiratory distress syndrome severity after adjustment for treatment characteristics. PLoS ONE 6: e18166. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0018166. Accessed 9 July 2012.
29. Akinnusi M, Pineda L, El Solh A, (2008) Effect of obesity on intensive care morbidity and mortality: a metaanalysis. Crit Care Med 36: 151-158.
30. Louie JK, Jean C, Acosta M, Samuel MC, Matyas BT, et al. (2012) A review of adult mortality due to 2009 pandemic (H1N1) influenza A in California. PLoS ONE 6: e18221.
31. Noah MA, Peek GJ, Finney SJ, Griffiths MJ, Harrison DA, et al. (2011) Referral to an extracorporeal membrane oxygenation centre and mortality among patients with severe 2009 influenza A(H1N1). JAMA 306: 1659-1668.
32. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D, Bailey M, Beca J, et al (2009) Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 302: 1888-1895.
33. To KK, Hung IF, Li IW, Lee KL, Koo CK, et al. (2010) Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 50: 850-859.
34. Lee N, Wong CK, Chan PK, Chan MC, Wong RY, et al. (2011) Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS ONE 6: e26050. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0026050. Accessed 9 July 2012.
35. Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, et al. (2010) Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care 14:R203. Available: http://ccforum.com/content/14/6/R203. Accessed 9 July 2012.
36. Ingram PR, Inglis T, Moxon D, Speers D, (2010) Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med 36: 528-532.
37. Blyth CC, Webb SA, Kok J, Dwyer DE, van Hal SJ, et al. (2012) The impact of bacterial and viral co-infection in severe influenza. Influenza Other Respi Viruses 2012, Apr 6. doi: 10.1111/j.1750-2659.2012.00360.x. [Epub ahead of print].
38. Wang Y, Beydoun MA, (2007) The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographical characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29: 6-28.
39. O'Dea JA, (2003) Differences in overweight and obesity among Australian school children of low and middle/high socioeconomic status. Med J Aust 179: 63.
40. Cohen S, (1999) Social status and susceptibility to respiratory infections. Ann N Y Acad Sci 896: 246-253.
41. Galarce EM, Minsky S, Viswanath K, (2011) Socioeconomic status, demographics, beliefs and A(H1N1) vaccine uptake in the United States. Vaccine 29: 5284-5289.
42. Australian Government Department of Health and Ageing. Australian influenza surveillance summary report no. 5. Reporting period: 30 January 2010-5 February 2010. Available: http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/ozflu2010.htm/File/ozflu-no5-2010.pdf. Accessed 9 July 2012.
43. Iwasenko JM, Cretikos M, Paterson DL, Gibb R, Webb SA, et al. (2010) Enhanced diagnosis of pandemic (H1N1) 2009 influenza infection using molecular and serological testing in intensive care unit patients with suspected influenza. Clin Infect Dis 51: 70-72.
44. Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, et al. (2011) Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection. Am J Respir Crit Care Med 183: 1207-1214.
45. Brun-Buisson C, Richard JM, Mercat A, Thiébaut AC, Brochard L, et al. (2011) Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 183: 1200-1206.
46. Fedson DS, (2006) Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin Infect Dis 43: 199-205.
47. Fedson DS, (2009) Meeting the challenge of influenza pandemic preparedness in developing countries. Emerg Infect Dis 15: 365-371.43.
48. Australian Government Department of Health and Ageing. The Australian Immunisation Handbook 9th Edition 2008: Influenza. Available: http://www.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook-influenza. Accessed 9 July 2012.
49. Department of Health. Green book 2006 (updated November 7, 2011): Chapter 19 Influenza. Available: http://www.dh.gov.uk/dr_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_131001.pdf. Accessed 9 July 2012.
50. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, et al. (2010) Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59(RR-8): 1-62.